Also I think that article clarified fir me why the "ex vivo" was not a negative, as I had initially thought. Obviously in the field of vaccines or cancer or many other indications, this process of editing cells then replacing them back into the donor certainly has merit.
- Forums
- ASX - By Stock
- PYC
- Ann: Successful Delivery of CRIPR/Cas9 into Cells ex vivo
PYC
pyc therapeutics limited
Add to My Watchlist
2.01%
!
$1.22

Ann: Successful Delivery of CRIPR/Cas9 into Cells ex vivo, page-32
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
$1.22 |
Change
-0.025(2.01%) |
Mkt cap ! $717.4M |
Open | High | Low | Value | Volume |
$1.27 | $1.27 | $1.22 | $72.05K | 58.65K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
3 | 44613 | $1.22 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$1.24 | 3848 | 6 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
3 | 44613 | 1.220 |
2 | 14512 | 1.215 |
1 | 5000 | 1.210 |
1 | 434 | 1.205 |
3 | 3833 | 1.200 |
Price($) | Vol. | No. |
---|---|---|
1.235 | 3848 | 6 |
1.240 | 698 | 1 |
1.245 | 9050 | 2 |
1.250 | 588 | 1 |
1.255 | 1502 | 2 |
Last trade - 12.11pm 08/08/2025 (20 minute delay) ? |
Featured News
PYC (ASX) Chart |